|
|
|
|
LEADER |
01395nam a2200241 a 4500 |
001 |
1793433 |
005 |
20171111234540.0 |
008 |
080110s2008 njua sb 001 0 eng |
020 |
|
|
|z 9780470050941 (hbk.)
|
040 |
|
|
|a CaPaEBR
|
050 |
1 |
4 |
|a RA401.5
|b .D48 2008eb
|
245 |
0 |
0 |
|a Development and approval of combination products
|b a regulatory perspective /
|c edited by Evan B. Siegel.
|
260 |
|
|
|a Hoboken, N.J. :
|b Wiley,
|c c2008.
|
300 |
|
|
|a xii, 215 p. :
|b ill.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Overview of combination products development and regulatory review / Evan B. Siegel -- Detailed regulatory approaches to development, review, and approval / James Barquest -- Nonclinical recommendations for successful characterization and development of combination drug products / Duane B. Lakings -- Clinical pharmacology and clinical development of combination products / Chaline Brown -- Regulatory strategy considerations for chemistry, manufacturing, and controls : an integrated approach / Patrick L. DeVillier.
|
650 |
|
0 |
|a Drug approval
|z United States.
|
650 |
|
0 |
|a Biological products
|z United States.
|
650 |
|
0 |
|a Medical instruments and apparatus
|z United States.
|
700 |
1 |
|
|a Siegel, Evan B.
|
710 |
2 |
|
|a ebrary, Inc.
|
856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10296672
|
952 |
|
|
|a CY-NiOUC
|b 5a0458826c5ad14ac1ed16d5
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|